These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 609319)

  • 1. [Value of CB 154 (Parlodel) in the inhibition of milk production during the immediate post-partum period].
    Monnier JC; Boulogne M; Lanciaux B; Dognin C; Denuit MP
    Lille Med; 1977 Nov; 22(9 Suppl 2):739-42. PubMed ID: 609319
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of a new anti-prolactin agent, Parlodel (CB 154) in the inhibition of postpartum lactation].
    Notter A; Panisset JF
    Lyon Med; 1977 Dec; 238(20):547-8. PubMed ID: 599954
    [No Abstract]   [Full Text] [Related]  

  • 3. [Usefulness of estradiol and parlodel in puerperal lactation inhibition].
    Myśkow M; Zalewski J
    Wiad Lek; 1980 Mar; 33(5):351-3. PubMed ID: 7376671
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of bromoergocryptine in physiological inhibition of lactation].
    Canales ES; Levinson G; González-Colindres J; de la Peña RO; Zárate A
    Ginecol Obstet Mex; 1975 Feb; 37(220):49-52. PubMed ID: 1123159
    [No Abstract]   [Full Text] [Related]  

  • 5. Short term treatment with bromocriptine--a new approach to prevention of puerperal lactation.
    Srivannaboon S; Thamanavat N
    J Med Assoc Thai; 1983 Sep; 66(9):547-50. PubMed ID: 6655397
    [No Abstract]   [Full Text] [Related]  

  • 6. [Postpartum myocardial infarction induced by Parlodel].
    Pop C; Metz D; Matei M; Wagner E; Tassan S; Elaerts J
    Arch Mal Coeur Vaiss; 1998 Sep; 91(9):1171-4. PubMed ID: 9805577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibition of puerperal lactation with bromocriptine, a report].
    Zubke W; Neeser E; Peters FD; Roemer VM
    Arch Gynecol; 1979 Jul; 228(1-4):586-7. PubMed ID: 485488
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical commentary: the bromocriptine (Parlodel) controversy and recommendations for lactation suppression.
    Rayburn WF
    Am J Perinatol; 1996 Feb; 13(2):69-71. PubMed ID: 8672187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Medicamentous ablactation post partum. Comparative study between bromocryptin (Parlodel) and methallenoestrol (Vallestril) as well as 2 combination variants of both preparations].
    Aljinovic A; Gunti J; Pusterla E
    Gynakol Rundsch; 1976; 16(4):276-80. PubMed ID: 1037395
    [No Abstract]   [Full Text] [Related]  

  • 10. [Inhibition of post-partum physiological milk secretion by caffeine dihydroergocryptine and dihydroergotoxine].
    Elsener M; Ferrafiat M; de Bruyn M; Jouhet P; Robert Y; Rouge PE
    Rev Fr Gynecol Obstet; 1988 Nov; 83(11):697-701. PubMed ID: 3144727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of the suppression of lactation and the influence on blood clotting with bromocriptine (CB 154) (Parlodel): a double blind comparison with diethylstilboestrol.
    Nilsen PA; Meling AB; Abildgaard U
    Acta Obstet Gynecol Scand; 1976; 55(1):39-44. PubMed ID: 766555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bromocriptine to prevent lactation.
    Med Lett Drugs Ther; 1980 May; 22(11):48. PubMed ID: 6990220
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bromocriptine and methergoline in the inhibition of puerperal lactation].
    Abate F; Oliva A; Baviera G; La Spada R; Leonardi R; Bellinvia G
    Minerva Ginecol; 1984 Jun; 36(6):303-6. PubMed ID: 6472723
    [No Abstract]   [Full Text] [Related]  

  • 14. The treatment of puerperal lactation with bromocriptine.
    Cooke I; Foley M; Lenton E; Preston E; Millar D; Jenkins A; Obiekwe B; McNeilly A; Parsons J; Kennedy G
    Postgrad Med J; 1976; 52suppl 1():75-80. PubMed ID: 959129
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ovulation following lactation inhibition with bromocryptin].
    Boer D; van Hoek A; Meuwissen JH
    Ned Tijdschr Geneeskd; 1980 Jan; 124(4):100-3. PubMed ID: 7374831
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of ergot alkaloid derivatives on milk secretion in the immediate postpartum period].
    Jolivet A; Robyn C; Huraux-Rendu C; Gautray JP
    J Gynecol Obstet Biol Reprod (Paris); 1978 Jan; 7(1):129-34. PubMed ID: 641312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of puerperal lactation. A double blind study of bromocriptine and placebo.
    Dewhurst CJ; Harrison RF; Biswas S
    Acta Obstet Gynecol Scand; 1977; 56(4):327-31. PubMed ID: 341635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The suppression of puerperal lactation with bromocriptine.
    O'Donoghue RF
    Ir Med J; 1977 Apr; 70(5):172-3. PubMed ID: 324946
    [No Abstract]   [Full Text] [Related]  

  • 19. [Value of a percutaneous estrogen solution in stopping lactation].
    Fournier S; Foucher E; Faguer B; Pathier D
    Rev Fr Gynecol Obstet; 1990 Dec; 85(12):715-9. PubMed ID: 2291059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bromocriptine and puerperal fertility].
    Grella P; Meneghetti G; Cecchetto A; Tasinazzo R
    Riv Ital Ginecol; 1980; 59(2-3):223-31. PubMed ID: 7196080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.